Q1 2019

2 GHP / Q1 2019 Editor’s Note , Welcome to the Q1 issue of Global Health & Pharma Magazine, your source for the latest news and features from across the healthcare and pharmaceutical industries. The healthcare and pharmaceutical sectors rely on innovation to make it prepared for the challenges of the future. It relies on constant adaptation and development - a chameleonic ability to change to the demands and needs of the market and sector. This distinguishes it from other industries, where development is not quite as integral to day to day operations. Innovation is the lifeblood of life sciences. Our inclusions for this month take this idea of revitalisation and renewal to heart, as they look to improve the industry to even greater heights. First up in the issue is Clyz Labs. Founded in 2017, Clyz Labs utilises cutting edge technological innovations to spearhead their work in lung cancer research. Following the lab’s recognition in GHP’s 2018 Life Sciences programme, we spoke with Dr Himanshu Kataria, CEO and Managing Director of Clyz Labs, to find out more. Elsewhere, Jan De Caluwe, a leading Implantologist in Antwerp, Belgium, offered insight into the Implantology’s immediate future. Recent years have triggered a paradigm shift in the industry, as it looks set to embrace the latest technological and operational advancements. Here at GHP Magazine, we hope that you enjoy reading this quarter’s issue and look forward to hearing from you soon. Laura Brookes, Editor Phone: +44 (0) 203 970 0082 Email: [email protected] Website: www.ghp-news.com AI Global Media, Ltd. (AI) takes reasonable measures to ensure the quality of the information on this web site. However, AI will not assume any legal liability or responsibility for the accuracy, correctness or completeness of any information that is available through this web site. If errors are brought to our attention, we will try to correct them. The information available through the website and our partner publications is for your general information and use and is not intended to address any particular finance or investment requirements. In particular, the information does not constitute any form of advice or recommendation by us or any of our partner publications and is not intended to be relied upon by users in making or refraining from making any investment or financial decisions. Appropriate independent advice should be obtained before making any such decision. Any arrangement made between you and any third party named in the site is at your sole risk and responsibility.

http://www.clyzlabs.co.uk/ http://www.ghp-news.com/